GC Biopharma Applies For MFDS Approval Of World’s First “Recombinant Anthrax Vaccine”
YONGIN, South Korea: GC Biopharma announced 1 Nov. 2023 that it has applied for the marketing approval of “GC1109”, an anthrax vaccine jointly developed by GC Biopharma and the Korea Disease Control and…
